Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis
Vioxx-like drugs may still be best treatment option, study suggests
February 8th, 2006
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis. In a January 2006 Nature Reviews of Drug Discovery article, researchers from Imperial College London and Queen Mary, University of London, examine the use of selective inhibitors of cyclo-oxygenase-2 (COX-2). They argue that although this class of drugs, which includes Vioxx, has been associated with an increase in the risk of cardiovascular events such as heart attacks and strokes in some patients, the same may be true for traditional non-steroid anti-inflammatory drugs (NSAIDs). ...
Source: Immunotherapy Weekly (2006-02-08)
|
